But now there is a hope that we may have a new measure of disease burden, called MRD or Minimum Residual Disease. Dr. Guido Tricot will be discussing MRD and its implications for the treatment of multiple myeloma. His work on improved disease measurement goes back over a decade, and he was one of the researchers at UAMS who developed the Total Therapy protocol. The IMF’s (International Myeloma Foundation) Black Swan initative is centered on finding a MRD measurement method which will tell when the disease has been eradicated down to the point at which CURE is achieved.
Dr. Tricot will be discussing the topic of MRD on the Cure Panel September 17th broadcast at 6:00 pm EST. You can sign up to ask questions on air, get details on how to listen live, or listen to a later broadcast if you CLICK HERE.
With MRD we should be able to determine if a treatment is working, and have an idea as to when the treatment has achieved the optimal result. We have an opportunity to make sure the treatment is NOT TOO HARD, NOT TOO LITTLE, BUT JUST RIGHT. Like an old boss of mine once said, “You can not manage that which you do not or can not measure.”
Finally we have an accurate measure with MRD .I believe we are at the cusp of a new era of myeloma treatment with a CURE within our grasp.